BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
48 results:

  • 1. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
    Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
    Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/stat3 signaling.
    Zhong Z; Zhong H
    Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. What Is New in Cutaneous T Cell Lymphoma?
    Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
    Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast cancer Cells by Promoting Apoptosis and Inhibiting the stat3/EMT Axis.
    Park SJ; Jung HJ
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ANXA1 Promotes Tumor Immune Evasion by Binding PARP1 and Upregulating stat3-Induced Expression of PD-L1 in Multiple cancers.
    Xiao D; Zeng T; Zhu W; Yu ZZ; Huang W; Yi H; Lu SS; Feng J; Feng XP; Wu D; Wen Q; Zhou JH; Yuan L; Zhuang W; Xiao ZQ
    Cancer Immunol Res; 2023 Oct; 11(10):1367-1383. PubMed ID: 37566399
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MARCO is a potential prognostic and immunotherapy biomarker.
    Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
    Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
    Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
    Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the stat3/PD-L1 axis.
    Wang X; Ren Z; Xu Y; Gao X; Huang H; Zhu F
    Environ Toxicol; 2023 Feb; 38(2):368-380. PubMed ID: 36399467
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Melanoma-associated macrophages-from molecular signals to therapeutic application].
    Chatziioannou E; Aydin SA; Forchhammer S; Sinnberg T; Eigentler T
    Dermatologie (Heidelb); 2022 Dec; 73(12):915-928. PubMed ID: 36394590
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
    Song J; Yang R; Wei R; Du Y; He P; Liu X
    Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. stat3, VEGF, and PSMA Expression Patterns in Malignant Peripheral Nerve Sheath Tumors, Malignant Melanomas, and Glioblastomas: Does Staining Percentage and Intensity Have an Effect on Survival?
    Coskun SK; Gamsizkan M; Yalcınkaya U; Sungur MA
    J Environ Pathol Toxicol Oncol; 2022; 41(1):45-53. PubMed ID: 35378003
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction.
    Landras A; Reger de Moura C; Villoutreix BO; Battistella M; Sadoux A; Dumaz N; Menashi S; Fernández-Recio J; Lebbé C; Mourah S
    Oncogene; 2022 Apr; 41(15):2254-2264. PubMed ID: 35217792
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.
    Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
    Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immune implication of an autophagy-related prognostic signature in uveal melanoma.
    Chuah S; Chew V
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34374416
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. stat3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
    Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
    J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
    Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A LHFPL3-AS1/miR-580-3p/stat3 Feedback Loop Promotes the Malignancy in Melanoma via Activation of JAK2/stat3 Signaling.
    Peng Q; Liu L; Pei H; Zhang J; Chen M; Zhai X
    Mol Cancer Res; 2020 Nov; 18(11):1724-1734. PubMed ID: 32753471
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of putative phenotype-modifying genetic factors associated with phenotypic diversity in Brooke-Spiegler syndrome.
    Pap ÉM; Farkas K; Széll M; Németh G; Rajan N; Nagy N
    Exp Dermatol; 2020 Oct; 29(10):1017-1020. PubMed ID: 32744342
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Downregulation of RIG-I mediated by ITGB3/c-SRC/stat3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
    Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. stat3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
    Gao H; Liu R; Sun X
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.